“A THREATENING RISE IN MELANCHOLIC STAGES AMONG YOUNG GENERATION: IS IT PANDEMIC OR SOMETHING ELSE”
Main Article Content
Keywords
Depression, Non-pharmacological treatment, Young generation, combat.
Abstract
Background: Depression is a disorder of low mood that comes under category of mental illness caused by sad feelings because of a particular reason. Depressive individuals mostly show a different attitude and they have a different mind-set like they mostly end up the situations or their decisions in pessimism, and suicidal.
Aims: The main aim of the study is to observe the depression in among young generation especially students of our society, with respect current pandemic condition, that how this situation is especially effecting student mind-set along with that also how we can combat with it, through available non-pharmacological options to comprehend with such situation young generations
Methodology: The study comprises two phases. Phase-I was mainly dependent on undertaking a cross-sectional survey study where we observed depression among the younger generation in our community using the HSLC-25 checklist to evaluate the stages of depression with respect to symptoms observed. Phase-II of the study mainly deals with non-pharmacological solution to combat depression.
Result: The result shows that depression is mainly entrenched in our society, especially among the young generation but there are many non-pharmacological solutions which can combat depression and may heal a person of its depressed state. The assessed data depicts a very clear picture of the significant influence that non-pharmacological treatment has on the management of anxiety and depression.
Conclusion: The study concludes that depression has risen in the study population in this particular span of the pandemic but it can be identified and easily be combatted with non-pharmacological treatments.
References
2. Marcus, M., et al., Depression: A global public health concern. 2012.
3. Organization, W.H., Depression and other common mental disorders: global health estimates. 2017, World Health Organization.
4. Duman, R.S., et al., Synaptic plasticity and depression: new insights from stress and rapid-acting antidepressants. Nature medicine, 2016. 22(3): p. 238-249.
5. Hidaka, B.H., Depression as a disease of modernity: explanations for increasing prevalence. Journal of affective disorders, 2012. 140(3): p. 205-214.
6. Çakıcı, M., et al., Depression: point-prevalence and risk factors in a North Cyprus household adult cross-sectional study. BMC psychiatry, 2017. 17(1): p. 1-11.
7. Karasu, T.B., et al., Treatment of patients with major depressive disorder. American Psychiatric Association Practice Guidelines for the Treatment of Psychiatric Disorders Compendium, 2000: p. 413-495.
8. Ren, X., et al., Burden of depression in China, 1990–2017: findings from the global burden of disease study 2017. Journal of affective disorders, 2020. 268: p. 95-101.
9. Majidi, M., et al., Associated factors with major depression: a path analysis on NHANES 2013–2014 study. International Journal of Culture and Mental Health, 2018. 11(4): p. 763-773.
10. Wallace, D.D., M.H. Boynton, and L.A. Lytle, Multilevel analysis exploring the links between stress, depression, and sleep problems among two-year college students. Journal of American college health, 2017. 65(3): p. 187-196.
11. Angkurawaranon, C., et al., Predictors of quality of life of medical students and a comparison with quality of life of adult health care workers in Thailand. Springerplus, 2016. 5(1): p. 1-9.
12. Brådvik, L., Suicide risk and mental disorders. 2018, MDPI. p. 2028.
13. Aaltonen, K.I., et al., Decline in suicide mortality after psychiatric hospitalization for depression in Finland between 1991 and 2014. World Psychiatry, 2018. 17(1): p. 110.
14. Gournellis, R., et al., Psychotic (delusional) depression and suicidal attempts: a systematic review and meta‐analysis. Acta Psychiatrica Scandinavica, 2018. 137(1): p. 18-29.
15. Organization., W.H. Suicide worldwide in 2019: global health estimates. . 2019 [cited 2019; Available from: https://www.who.int/publications/i/item/97892400.
16. Bachmann, S., Epidemiology of suicide and the psychiatric perspective. International journal of environmental research and public health, 2018. 15(7): p. 1425.
17. Liu, Y., et al., The prevalence and trend of depression among veterans in the United States. Journal of affective disorders, 2019. 245: p. 724-727.
18. Portnoff, L., et al., Spirituality cuts in half the relative risk for depression: Findings from the United States, China, and India. Spirituality in Clinical Practice, 2017. 4(1): p. 22.
19. Banerjee, D., How COVID-19 is overwhelming our mental health. Nature India, 2020. 26: p. 2020.
20. Wind, T.R., et al., The COVID-19 pandemic: The ‘black swan’for mental health care and a turning point for e-health. Internet interventions, 2020. 20.
21. Al-Harbi, K.S., Treatment-resistant depression: therapeutic trends, challenges, and future directions. Patient preference and adherence, 2012. 6: p. 369.
22. Li, J., Y.-L. Theng, and S. Foo, Effect of exergames on depression: a systematic review and meta-analysis. Cyberpsychology, Behavior, and Social Networking, 2016. 19(1): p. 34-42.
23. Ventevogel, P., et al., Properties of the Hopkins Symptom Checklist-25 (HSCL-25) and the Self-Reporting Questionnaire (SRQ-20) as screening instruments used in primary care in Afghanistan. Social psychiatry and psychiatric epidemiology, 2007. 42(4): p. 328-335.
24. Sandanger, I., et al., Concordance between symptom screening and diagnostic procedure: the Hopkins Symptom Checklist-25 and the Composite International Diagnostic Interview I. Social psychiatry and psychiatric epidemiology, 1998. 33(7): p. 345-354.
25. Olsen, C. and D. St George, Cross-sectional study design and data analysis. College entrance examination board, 2004. 26(03): p. 2006.
26. Bantjes, J., A. Kagee, and W. Saal, The Utility of the Hopkins Symptom Checklist as a Trans-Diagnostic Screening Instrument for Common Mental Disorders Among Persons Seeking HIV Testing. AIDS and Behavior, 2020. 24(2): p. 629-636.
27. Apóstolo, J., et al., The effectiveness of non-pharmacological interventions in older adults with depressive disorders: a systematic review. International journal of nursing studies, 2016. 58: p. 59-70.
28. Farah, W.H., et al., Non-pharmacological treatment of depression: a systematic review and evidence map. BMJ evidence-based medicine, 2016. 21(6): p. 214-221.
29. Ventevogel, P., et al., Properties of the Hopkins Symptom Checklist-25 (HSCL-25) and the Self-Reporting Questionnaire (SRQ-20) as screening instruments used in primary care in Afghanistan. Social psychiatry and psychiatric epidemiology, 2007. 42: p. 328-335.
30. Skogen, J.C., et al., The factor structure of the Hopkins Symptoms Checklist (HSCL-25) in a student population: a cautionary tale. Scandinavian journal of public health, 2017. 45(4): p. 357-365.
31. Gartlehner, G., et al., Pharmacological and non-pharmacological treatments for major depressive disorder: review of systematic reviews. BMJ open, 2017. 7(6): p. e014912.
32. Schmalbach, B., et al., Psychometric properties of two brief versions of the Hopkins symptom checklist: HSCL-5 and HSCL-10. Assessment, 2021. 28(2): p. 617-631.
33. Haavet, O.R., et al., Diagnosis of depressed young people in primary health care—a validation of HSCL-10. Family practice, 2011. 28(2): p. 233-237.
34. Ibrahim, A.K., et al., A systematic review of studies of depression prevalence in university students. Journal of psychiatric research, 2013. 47(3): p. 391-400.
35. Gelenberg, A.J., The prevalence and impact of depression. The Journal of clinical psychiatry, 2010. 71(3): p. 0-0.
Article Sidebar
Article Details
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
All articles published in JPTCP are licensed under Copyright Creative Commons Attribution-NonCommercial 4.0 International License.
Javeria Sheikh
Lecturer, Department of Pharmaceutics, Faculty of Pharmacy, Jinnah University for Women, Karachi, Pakistan.
Prof. Dr. Amber Nawab
Professor, Department of Pharmaceutics, Faculty of Pharmacy, Jinnah University for Women, Karachi, Pakistan.
Sumaira Khadim
Lecturer, Department of Pharmaceutics, Faculty of Pharmacy, Iqra University, Karachi, Pakistan.
Sidra Sohail Asim
Cooperative Lecturer, Department of Pharmaceutics, Faculty of Pharmacy, Jinnah University for Women, Karachi, Pakistan.
Asra Mansoor
Lecturer, Department of Pharmaceutics, Faculty of Pharmacy, Jinnah University for Women, Karachi, Pakistan.
Ayesha Akhtar
Lecturer, Department of Pharmaceutics, Faculty of Pharmacy, Jinnah University for Women, Karachi, Pakistan.
Ayesha Kiran
Lecturer, Department of Pharmacology, Faculty of Pharmacy, Jinnah University for Women, Karachi, Pakistan.
Shazma
Lecturer, Department of Pharmacognosy, Faculty of Pharmacy, Jinnah University for Women, Karachi, Pakistan.